These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7882283)

  • 1. Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma.
    Levesque MA; Katsaros D; Yu H; Zola P; Sismondi P; Giardina G; Diamandis EP
    Cancer; 1995 Mar; 75(6):1327-38. PubMed ID: 7882283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival.
    Angelopoulou K; Rosen B; Stratis M; Yu H; Solomou M; Diamandis EP
    Cancer; 1996 Nov; 78(10):2146-52. PubMed ID: 8918407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p53 immunostaining in epithelial ovarian cancer.
    Hartmann LC; Podratz KC; Keeney GL; Kamel NA; Edmonson JH; Grill JP; Su JQ; Katzmann JA; Roche PC
    J Clin Oncol; 1994 Jan; 12(1):64-9. PubMed ID: 8270986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of p53 expression quantitated by computerized image analysis in epithelial ovarian cancer.
    Anttila MA; Ji H; Juhola MT; Saarikoski SV; Syrjänen KJ
    Int J Gynecol Pathol; 1999 Jan; 18(1):42-51. PubMed ID: 9891240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma.
    Klemi PJ; Pylkkänen L; Kiilholma P; Kurvinen K; Joensuu H
    Cancer; 1995 Oct; 76(7):1201-8. PubMed ID: 8630898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
    Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
    Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
    Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
    Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.
    van der Zee AG; Hollema H; Suurmeijer AJ; Krans M; Sluiter WJ; Willemse PH; Aalders JG; de Vries EG
    J Clin Oncol; 1995 Jan; 13(1):70-8. PubMed ID: 7799045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
    Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
    J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters].
    Casper F; Weikel W; Schaffrath M; Kuner RP; Hoffmann G; Pollow B; Pollow K
    Zentralbl Gynakol; 2000; 122(3):153-9. PubMed ID: 10756599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.
    Diebold J; Baretton G; Felchner M; Meier W; Dopfer K; Schmidt M; Löhrs U
    Am J Clin Pathol; 1996 Mar; 105(3):341-9. PubMed ID: 8602616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow.
    Schindlbeck C; Hantschmann P; Zerzer M; Jahns B; Rjosk D; Janni W; Rack B; Sommer H; Friese K
    Int J Gynecol Cancer; 2007; 17(5):1047-55. PubMed ID: 17433065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: prognostic significance.
    Suzuki M; Ohwada M; Saga Y; Kohno T; Takei Y; Sato I
    Oncology; 2001; 60(2):170-5. PubMed ID: 11244333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy.
    Nakayama K; Kanzaki A; Terada K; Mutoh M; Ogawa K; Sugiyama T; Takenoshita S; Itoh K; Yaegashi N; Miyazaki K; Neamati N; Takebayashi Y
    Clin Cancer Res; 2004 Apr; 10(8):2804-11. PubMed ID: 15102688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer.
    Skírnisdóttir I; Seidal T
    Int J Gynecol Cancer; 2011 Aug; 21(6):1024-31. PubMed ID: 21792012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 accumulation in ovarian carcinomas and its prognostic implications.
    Bosari S; Viale G; Radaelli U; Bossi P; Bonoldi E; Coggi G
    Hum Pathol; 1993 Nov; 24(11):1175-9. PubMed ID: 8244317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Overexpression of p53 protein in ovarian carcinomas: correlation with histopathologic data and clinical course].
    Reles A; Press MF; Schönborn I; Lichtenegger W; Strohmeyer T
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():93-7. PubMed ID: 8672936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
    Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
    J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.